Mark Juneau Jr, MD | |
920 Avenue B, Marrero, LA 70072-3112 | |
(504) 349-6804 | |
(504) 349-6844 |
Full Name | Mark Juneau Jr |
---|---|
Gender | Male |
Speciality | Orthopaedic Surgery |
Location | 920 Avenue B, Marrero, Louisiana |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669421533 | NPI | - | NPPES |
1792217 | Other | LA | MEDICAID GROUP |
CK4990 | Other | LA | RAILROAD MEDICARE GROUP |
1181218 | Medicaid | LA | |
5B353 | Other | LA | MEDICARE GROUP |
200009061 | Other | LA | RR MEDICARE INDIVIDUAL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 12292 (Louisiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mark Juneau Jr, MD 920 Avenue B, Marrero, LA 70072-3112 Ph: (504) 349-6804 | Mark Juneau Jr, MD 920 Avenue B, Marrero, LA 70072-3112 Ph: (504) 349-6804 |
News Archive
Origin Biotechnology, a wholly-owned subsidiary of Origin Agritech Limited announced it has reached an comprehensive, worldwide agreement with the Institute of Plant Protection, Chinese Academy of Agricultural Sciences (CAAS). CAAS jointly own the rights to the internally developed Bt-gene.
Recognizing that each patient's labor and delivery experience is unique, the American Society of Anesthesiologists (ASA) Practice Guidelines for Obstetric Anesthesia were recently revised to enhance the quality of anesthetic care for obstetric patients, improve patient safety by reducing the incidence and severity of anesthesia-related complications, and increase patient satisfaction.
NexMed, Inc, a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the Company has filed an Investigational New Drug (IND) application with the U.S. Food & Drug Administration (FDA) for a Phase II trial of its recently acquired cancer drug candidate PrevOnco™, in combination with doxorubicin in patients with advanced, unresectable hepatocellular carcinoma (HCC). The FDA has 30 days to comment on the IND before NexMed can proceed with human testing.
Patients with chronic obstructive pulmonary disease who are infected with Pseudomonas aeruginosa have a worse clinical outcome and are more likely to be hospitalized than those without the infection, states recent research.
› Verified 4 days ago
Ralph P Katz, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1301 Barataria Blvd, Marrero, LA 70072 Phone: 504-347-0243 Fax: 504-349-2910 | |
Wesley Allen Clark, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 920 Avenue B, Marrero, LA 70072 Phone: 504-349-6804 Fax: 504-349-6844 | |
Lucas Thomas Cashio, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 920 Avenue B, Marrero, LA 70072 Phone: 504-349-6804 Fax: 504-349-6844 | |
Matthew R Grimm, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 920 Avenue B, Marrero, LA 70072 Phone: 504-349-6804 Fax: 504-349-6844 | |
Dr. Daniel James Gallagher, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4633 Wichers Dr, Marrero, LA 70072 Phone: 504-347-5421 Fax: 504-378-9331 | |
Chris J Digrado, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1301 Barataria Blvd, Marrero, LA 70072 Phone: 504-347-0243 Fax: 504-349-2910 |